Pneumonia D011014

Diseases [C] » Infections [C01] » Respiratory Tract Infections » Pneumonia

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Pneumonia

Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Pneumonia

Description

Infection of the lung often accompanied by inflammation.   MeSH

Hierarchy View

Subtype Terms (8)

Bronchopneumonia
1 experimental drug

Healthcare-Associated Pneumonia
73 drugs (52 approved, 21 experimental)

Pleuropneumonia
10 drugs (9 approved, 1 experimental)

Pneumonia, Aspiration
12 drugs (10 approved, 2 experimental)

Pneumonia, Bacterial
86 drugs (54 approved, 32 experimental)

Pneumonia, Necrotizing
 

Pneumonia, Pneumocystis
28 drugs (22 approved, 6 experimental)

Pneumonia, Viral
12 drugs (11 approved, 1 experimental)


Phase 4 Indicated Drugs (74)

Key: D011014 (73) Subtype (1)

Phase 3 Indicated Drugs (95)

Phase 2 Indicated Drugs (93)


Organization Involved with Phase 4 Indications (132)

Key: D011014 (130) Subtype (2)

Organization Involved with Phase 3 Indications (135)

Organization Involved with Phase 2 Indications (92)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.